Eyebright Medical Successfully Concludes Participation in Hong Kong International Optical Fair 2026

LeBleu® and KAMIYA Make Debut in Hong Kong, Drawing Widespread Industry Attention

HONG KONG, Nov. 13, 2026 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Co., Ltd. (referred to as "Eyebright Medical", Stock Code: 688050.SH) completed its participation in the Hong Kong International Optical Fair 2026. Held from November 4 to 6, 2026, at the Hong Kong Convention and Exhibition Centre, the fair serves as a trade event for the optometry and eyewear industry, bringing together global buyers, eye care professionals, and brand representatives as a platform for technology exchange and international channel expansion.

At this year's exhibition, Eyebright Medical presented its vision care brand portfolio. Driven by the steady growth of the group's vision care sector, the dual brands LeBleu® and KAMIYA made a simultaneous appearance, showcasing Eyebright Medical's end-to-end R&D, manufacturing, and sales capabilities to partners across the Asia-Pacific region.

As Eyebright Medical's representative brand for contact lenses, LeBleu® incorporates the group's R&D capabilities in optical design and manufacturing. Backed by Eyebright Medical's R&D team of over 300 professionals and two self-owned, GMP-certified smart manufacturing bases — Jiangsu Tianyan Medical and Fujian Evercon, with a combined standardized R&D and production space of over 120,000 square meters. LeBleu® maintains end-to-end control over material R&D, optical design, manufacturing, and quality control, safeguarding product stability and wearing safety at the source.

LeBleu® presented several product series at the fair, including silicone hydrogel series, EDF aspheric daily disposable contact lenses, EDF+ high-order aspheric bi-weekly and half-year disposable contact lenses, and Toric color contact lenses. The product line incorporates Extended Depth of Focus (EDF) aspheric optical design alongside storage solution formulations containing Vitamin B12 and Hyaluronic Acid tailored for daily wear.

Sharing the spotlight was KAMIYA, an emerging color contact lens brand, which showcased its Spotlight Series Toric Color Contact Lenses in their Hong Kong debut. As Eyebright Medical's brand in the color lens segment, KAMIYA focuses on consumer preferences for fashion aesthetics and product value. Supported by Eyebright Medical's manufacturing infrastructure and digital quality control, KAMIYA maintains batch-level product traceability. Furthermore, utilizing high-speed AOI optical inspection systems and supply chain management, KAMIYA optimizes its cost structure to deliver accessible pricing.

The sample trial sessions during the exhibition generated strong interest. Channel partners from Hong Kong, Macao, and Southeast Asia inquired about product registration, packaging localization, and market promotion strategies, evaluating the commercial potential of color lens brands among young Asia-Pacific consumers.

Eyebright Medical's participation attracted media coverage and on-site interviews. Mr. Jia Baoshan, Deputy General Manager and Sales and Market Sales Director of Eyebright Medical Technology (Beijing) Co., Ltd., together with Ms. Zhou Yuxi, General Manager of Eyebright Medical's Hong Kong subsidiary, jointly participated in media interviews and shared the group's operational developments, outlining Eyebright Medical's international growth orientation and overall business structure. The organizer, Hong Kong Trade Development Council, also highlighted Eyebright Medical as an exhibitor case study across official event communications.

As an international hub connecting Mainland China with global markets, Hong Kong serves as a strategic node for Eyebright Medical's regional roadmap. Leveraging Hong Kong's business network and regulatory framework, Eyebright Medical's local team continues to advance international registration, academic engagement, and channel development across its vision care and ophthalmic device portfolios.

About Eyebright Medical Technology (Beijing) Co., Ltd.

Eyebright Medical Technology (Beijing) Co., Ltd. is listed on the STAR Market of the Shanghai Stock Exchange (Stock Abbreviation: Eyebright Medical, Stock Code: 688050.SH). Located in Zhongguancun Science Park, Beijing, it is a National High-Tech Enterprise and a recognized National "Little Giant" Enterprise specializing in niche markets. As an innovation-driven high-end medical device manufacturer with a global vision, Eyebright Medical has strategically laid out its presence across four high-potential sectors: ophthalmic surgical treatments, myopia management, consumer vision care, and sports medicine. Leveraging deep technical barriers and robust commercialization capabilities, the company is positioning itself among global medical technology leaders as a representative of China's intelligent manufacturing strength.

SOURCE Eyebright Medical Technology (Beijing) Co., Ltd.